Anika Therapeutics, Inc. Total Contract Liability
Anika Therapeutics, Inc. (ANIK) had Total Contract Liability of $0 as of 2025-12-31, per its 10-K filed 2026-03-03.
Financial Statements › Balance Sheet › Liabilities
us-gaap:ContractWithCustomerLiability · last filed 2026-03-03
- 2025-12-31: Contract with Customer, Liability $0.00.
- 2024-12-31: Contract with Customer, Liability $0.00.
- 2023-12-31: Contract with Customer, Liability $0.00.
- 2022-12-31: Contract with Customer, Liability $0.00.
| Period end | Contract with Customer, Liability |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-03 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-03 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-17 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-15 |
| 2022-09-30 | $100.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $300.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $300.00K 10-Q · filed 2022-05-06 |
| 2021-12-31 | $1.00M 10-K · filed 2023-03-16 |
| 2021-09-30 | $900.00K 10-Q · filed 2021-11-05 |
| 2021-06-30 | $900.00K 10-Q · filed 2021-08-06 |
| 2021-03-31 | $900.00K 10-Q · filed 2021-05-07 |
| 2021-01-01 | $1.00M 10-K · filed 2022-03-11 |
| 2020-12-31 | $200.00K 10-K · filed 2022-03-11 |
| 2020-03-31 | $100.00K 10-Q · filed 2020-05-22 |
| 2019-12-31 | $0.00 10-K/A · filed 2021-04-26 |
| 2019-09-30 | $28.00K 10-Q · filed 2019-10-28 |
| 2019-06-30 | $50.00K 10-Q · filed 2019-07-26 |
| 2019-03-31 | $67.00K 10-Q · filed 2019-05-06 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-06 |
| 2018-09-30 | $52.00K 10-Q · filed 2018-10-26 |
| 2018-06-30 | $100.00K 10-Q · filed 2018-07-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |